XOMA 129

• Description:

  XOMA 129 is a human monoclonal antibody targeting INSR. XOMA 129 is an insulin receptor (IR) antagonist that inhibits the drop in blood glucose. XOMA 129 can be used in the study of hypoglycemia [1].

• UNSPSC:

  12352203

• Target:

  Insulin Receptor

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Endocrinology

• Smiles:

  [XOMA 129]

• References & Citations:

  [1]Li O, et al. XOMA 129, a Novel Insulin Receptor Negative Modulator, Is Efficacious in Treating Insulin-Induced Hypoglycemia in Minipigs[J]. Blood, 2017, 200 (100) : 0.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported